Reuters logo
BRIEF-FDA approves new indication for Ipsen's somatuline depot injection
September 18, 2017 / 12:27 PM / 3 months ago

BRIEF-FDA approves new indication for Ipsen's somatuline depot injection

Sept 18 (Reuters) - Ipsen Sa

* U.S. FDA approves new indication for Ipsen’s somatuline® depot (lanreotide) injection for the treatment of carcinoid syndrome Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below